CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
6125 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C01301 | BRD-K34303607 | CKI-7 | CSNK1G2 | casein kinase inhibitor | Details | |
C01302 | BRD-K00662280 | CL-218872 | GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2 | benzodiazepine receptor agonist | Details | |
C01303 | BRD-K87573013 | CL-225385 | Details | |||
C01304 | BRD-K93034159 | cladribine | ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B | adenosine deaminase inhibitor; ribonucleotide reductase inhibitor | Details | |
C01305 | BRD-K49668410 | clarithromycin | CYP3A4 | bacterial 50S ribosomal subunit inhibitor | Details | |
C01306 | BRD-K94250879 | clavulanate | beta lactamase inhibitor | Details | ||
C01307 | BRD-K17294426 | clebopride | ACHE|DRD2 | dopamine receptor antagonist | Details | |
C01308 | BRD-K30240666 | clemastine | HRH1 | histamine receptor antagonist | Details | |
C01309 | BRD-K04704168 | clemizole | HCV inhibitor | Details | ||
C01310 | BRD-A75726477 | clenbuterol | ADRB1|ADRB2|ADRB3|NGF|TNF | adrenergic receptor agonist | Details | |
C01311 | BRD-A01563671 | cleviprex | CACNA1C|CACNA1D|CACNA1F|CACNA1S | calcium channel blocker | Details | |
C01312 | BRD-K18948558 | clevudine | DNA polymerase inhibitor | Details | ||
C01313 | BRD-A46066006 | clidinium | CHRM1|CHRM3 | acetylcholine receptor antagonist | Details | |
C01314 | BRD-A61676498 | climbazole | enzyme inducer | Details | ||
C01315 | BRD-A93964801 | clinafloxacin | bacterial DNA gyrase inhibitor | Details | ||
C01316 | BRD-K23586533 | clindamycin | protein synthesis inhibitor | Details | ||
C01317 | BRD-A76672327 | clindamycin-palmitate | bacterial 50S ribosomal subunit inhibitor | Details | ||
C01318 | BRD-K27771035 | clindamycin-phosphate | protein synthesis inhibitor | Details | ||
C01319 | BRD-A90625545 | clinofibrate | LPL | lipase clearing factor inhibitor | Details | |
C01320 | BRD-K09255212 | clioquinol | OPRK1 | chelating agent | Details | |
C01321 | BRD-K52408781 | clobazam | GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ | GABA benzodiazepine site receptor agonist | Details | |
C01322 | BRD-K71430621 | clobenpropit | HRH1|HRH2|HRH3|HRH4 | histamine receptor antagonist | Details | |
C01323 | BRD-K10799896 | clobetasol-propionate | NR3C1|PLA2G1B | glucocorticoid receptor agonist | Details | |
C01324 | BRD-K58810291 | clobetasone-butyrate | NR3C1 | corticosteroid agonist | Details | |
C01325 | BRD-A43809092 | clobutinol | antitussive | Details | ||
C01326 | BRD-K38003476 | clocortolone-pivalate | NR3C1|PLA2G1B | steroid | Details | |
C01327 | BRD-K72542090 | clodronic-acid | SLC25A4|SLC25A5|SLC25A6 | bone resorption inhibitor | Details | |
C01328 | BRD-K34022604 | clofarabine | POLA1|POLD1|POLE|RRM1|RRM2|RRM2B | ribonucleotide reductase inhibitor | Details | |
C01329 | BRD-K56614220 | clofazimine | GK0582 inhibitor | Details | ||
C01330 | BRD-A15687940 | clofedanol | HRH1 | histamine receptor antagonist | Details | |
C01331 | BRD-K45252063 | clofibrate | LPL|PPARA | PPAR receptor agonist | Details | |
C01332 | BRD-K19111024 | clofibric-acid | PPARA | PPAR receptor agonist | Details | |
C01333 | BRD-K02680176 | clofilium | KCNA5|KCNH1 | potassium channel blocker | Details | |
C01334 | BRD-K02900412 | clofoctol | protein synthesis inhibitor | Details | ||
C01335 | BRD-K39230570 | clomesone | DNA inhibitor | Details | ||
C01336 | BRD-K50422030 | clomethiazole | GABRA1 | GABA receptor antagonist; GABA receptor modulator | Details | |
C01337 | BRD-K29950728 | clomifene | ESR1 | estrogen receptor antagonist | Details | |
C01338 | BRD-K52989797 | clomipramine | GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4 | serotonin transporter (SERT) inhibitor | Details | |
C01339 | BRD-K38183498 | clonazepam | GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|TSPO | GABA benzodiazepine site receptor agonist | Details | |
C01340 | BRD-K98530306 | clonidine | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C | adrenergic receptor agonist | Details | |
C01341 | BRD-M63173034 | clonixin-lysinate | cyclooxygenase inhibitor | Details | ||
C01342 | BRD-A85651701 | clopamide | sodium/chloride cotransporter inhibitor | Details | ||
C01343 | BRD-A80908310 | cloperastine | antitussive | Details | ||
C01344 | BRD-K27721098 | clopidogrel | P2RY12 | purinergic receptor antagonist | Details | |
C01345 | BRD-K80036624 | clopidol | Details | |||
C01346 | BRD-K17850764 | cloprostenol-(+/-) | PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R | prostaglandin receptor agonist | Details | |
C01347 | BRD-A04971881 | cloranolol | ADRB1|ADRB2|ADRB3 | adrenergic receptor antagonist | Details | |
C01348 | BRD-K73251053 | clorgiline | MAOA | monoamine oxidase inhibitor | Details | |
C01349 | BRD-A19053834 | clorotepine | ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6 | dopamine receptor antagonist; adrenergic receptor antagonist | Details | |
C01350 | BRD-A29281099 | clorprenaline | ADRB1|ADRB2 | adrenergic receptor agonist | Details | |
C01351 | BRD-K97521363 | clorsulon | glycolysis inhibitor | Details | ||
C01352 | BRD-A19952358 | closantel | chitinase inhibitor; NFkB pathway inhibitor | Details | ||
C01353 | BRD-K10990317 | clotiapine | Details | |||
C01354 | BRD-K15916496 | clotrimazole | CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8 | cytochrome P450 inhibitor; imidazoline receptor ligand | Details | |
C01355 | BRD-K01244426 | cloxacillin | bacterial cell wall synthesis inhibitor | Details | ||
C01356 | BRD-K46982791 | cloxyquin | KCNK18 | potassium channel activator | Details | |
C01357 | BRD-K37289225 | clozapine | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7 | dopamine receptor antagonist; serotonin receptor antagonist | Details | |
C01358 | BRD-K06467130 | CL316243 | ADRB3|UCP1|UCP2|UCP3 | adrenergic receptor agonist | Details | |
C01359 | BRD-K54095730 | CMPD-1 | GNRHR|MAPK14 | p38 MAPK inhibitor | Details | |
C01360 | BRD-K19438463 | CNQX | GRIA1|GRIA2|GRIA3|GRIA4 | glutamate receptor antagonist | Details | |
C01361 | BRD-K24869513 | CNX-2006 | EGFR | EGFR inhibitor | Details | |
C01362 | BRD-K48443249 | CNX-774 | BTK | Bruton's tyrosine kinase (BTK) inhibitor | Details | |
C01363 | BRD-K55677650 | CO-101244 | GRIN2B | glutamate receptor antagonist | Details | |
C01364 | BRD-K70912147 | co-102862 | SCN4A|SCN9A | Details | ||
C01365 | BRD-K51040301 | cobicistat | CYP3A4|CYP3A43|CYP3A5|CYP3A7 | cytochrome P450 inhibitor | Details | |
C01366 | BRD-K03390685 | cobimetinib | MEK inhibitor | Details | ||
C01367 | BRD-A67956599 | coenzyme-a | ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5 | Details | ||
C01368 | BRD-A84188517 | coenzyme-i | AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH | Details | ||
C01369 | BRD-K75043328 | coenzyme-q10 | Details | |||
C01370 | BRD-K00259736 | colchicine | GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8 | microtubule inhibitor | Details | |
C01371 | BRD-U08520523 | colesevalam | Details | |||
C01372 | BRD-A55416093 | colforsin | ADCY2|ADCY5 | adenylyl cyclase activator | Details | |
C01373 | BRD-K19388745 | colforsin-daproate | adenylyl cyclase activator | Details | ||
C01374 | BRD-A95886749 | colfosceril-palmitate | pulmonary surfactant | Details | ||
C01375 | BRD-A13668387 | colistimethate | bacterial permeability inducer | Details | ||
C01376 | BRD-A18924964 | colistin | bacterial permeability inducer | Details | ||
C01377 | BRD-A36456202 | colistin-b-sulfate | bacterial permeability inducer | Details | ||
C01378 | BRD-A45201156 | colistin-sulfate | bacterial permeability inducer | Details | ||
C01379 | BRD-K61195623 | combretastatin-A-4 | tubulin polymerization inhibitor | Details | ||
C01380 | BRD-K98143539 | compound-w | BACE1 | beta-secretase inhibitor | Details | |
C01381 | BRD-K19655798 | compound-401 | MTOR|PRKDC | DNA dependent protein kinase inhibitor | Details | |
C01382 | BRD-K76139886 | compound-58112 | Details | |||
C01383 | BRD-K37385792 | conivaptan | AVPR1A|AVPR2 | vasopressin receptor antagonist | Details | |
C01384 | BRD-K24666289 | copanlisib | PIK3CA|PIK3CB|PIK3CD|PIK3CG | PI3K inhibitor | Details | |
C01385 | BRD-K36449075 | copper-histidine | HAL|HARS|HDC|SLC15A3|SLC15A4|SLC38A3|SLC38A5 | Details | ||
C01386 | BRD-K74965187 | COR-170 | CNR2 | cannabinoid receptor inverse agonist | Details | |
C01387 | BRD-K65428967 | cordycepin | DNA inhibitor | Details | ||
C01388 | BRD-K27885593 | corosolic-acid | HSD11B1|PTPN1 | PKC inhibitor; protein tyrosine kinase inhibitor | Details | |
C01389 | BRD-K73589401 | corticosterone | HSD11B1|NCOA1|NR3C2 | mineralocorticoid receptor agonist | Details | |
C01390 | BRD-A62731508 | cortisone | NR3C1 | glucocorticoid receptor agonist | Details | |
C01391 | BRD-K86161929 | cortisone-acetate | NR3C1 | glucocorticoid receptor agonist | Details | |
C01392 | BRD-K43736954 | cortodoxone | AR | androgen receptor antagonist | Details | |
C01393 | BRD-K26833429 | costunolide | telomerase inhibitor | Details | ||
C01394 | BRD-K98710228 | cot-inhibitor-1 | MAP3K8 | MAPK-interacting kinase inhibitor | Details | |
C01395 | BRD-K49468759 | cot-inhibitor-2 | MAP3K8 | MAPK-interacting kinase inhibitor | Details | |
C01396 | BRD-K94144010 | cotinine | nicotine metabolite | Details | ||
C01397 | BRD-K23913458 | coumarin | CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6 | vitamin K antagonist | Details | |
C01398 | BRD-K41567533 | coumophos | cholinesterase inhibitor | Details | ||
C01399 | BRD-K53913008 | CP-316819 | PYGL | glycogen phosphorylase inhibitor | Details | |
C01400 | BRD-K52113681 | CP-339818 | KCNA3 | potassium channel blocker | Details |